The Formulary Committee assists the commissioner of human services in managing the medical assistance (MA) and MinnesotaCare drug benefit. Duties of the committee include reviewing and recommending drugs for prior authorization and for placement on the preferred drug list. This bill modifies the membership of the committee, modifies public notice requirements related to changes to the preferred drug list, extends the sunset of the formulary committee until June 30, 2027, and makes related changes.